Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism

The risk of hyperkalaemia in patients with heart failure has increased in the past few years together with the evolution of pharmacological treatment for these patients. This significant change has been associated with the introduction of angiotensin converting enzyme (ACE) inhibitors, angiotensin I...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Postgraduate medical journal 2010-03, Vol.86 (1013), p.136-142
Hauptverfasser:	Poggio, Rosana, Grancelli, Hugo O, Miriuka, Santiago G
Format:	Artikel
Sprache:	eng
Schlagworte:	Aldosterone - physiology Beta blockers Biological and medical sciences Cardiology. Vascular system Diuretics Diuretics - adverse effects Evidence-Based Medicine - methods General aspects Heart Heart attacks Heart failure Heart Failure - drug therapy Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Hyperkalemia - etiology Hyperkalemia - physiopathology Hyperkalemia - prevention & control Medical sciences Mineralocorticoid Receptor Antagonists - adverse effects Mortality potassium spironolactone Spironolactone - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!